66results about How to "High dependence" patented technology

A light emitting OLED apparatus comprising a microcavity OLED device having a broad-band light emitting organic EL element and configured to have angular-dependent narrow-band light emission, and a patterned light-integrating element provided over a portion of a light emitting region of the microcavity device, wherein the light-integrating element integrates the angular-dependent narrow-band emission from different angles from the microcavity OLED device to form an integrated light emission with decreased angular dependence in accordance with the pattern of the light-integrating element, and the apparatus maintains relatively angular-dependent emission in light emitting regions of the microcavity device not provided with the light-integrating element.

An optical fibre for transmission of light at a predetermined wavelength, the fibre having a core region, an inner cladding region and an outer cladding region, the inner cladding region having spaced apart voids, at least some of which are at least partly filled with a fluid substance to modify a refractive index in the cross-section of the fibre. The fluid substance may be introduced by preparing and fixing the fiber ends, identifying the voids to be filled and infusing the fluid therein while masking openings in the remaining voids. By selective heating of parts of the fibre, the location of the fluid substance in the void may be controlled to extend over only a fraction of the length of a void that extends the length by the fibre.

A transfer member is used in a transfer portion of an image forming apparatus. The transfer member includes an electrically conductive member that contacts a toner image bearing member of the image forming apparatus. The electrically conductive member is made of polyurethane resin to which electrically conducive polymer is added. An adding amount of the electrically conductive polymer with respect to the polyurethane resin is from 8 wt % to 40 wt %.

The present invention provides a method of manufacturing an organic light-emitting device which is applicable to a large-screen display device. The method includes the steps of: forming, over a drive substrate, an element region including a drive transistor, and an organic electroluminescence element in which, an anode, an organic layer and a cathode are stacked in this order; and after the formation of the element region, repairing a short circuit area while setting at least the element region in an atmosphere in which an oxygen concentration is 0.1% or higher and less than 1% and a dew point is −50 degrees or less, and applying a voltage across the anode and the cathode.

A semiconductor light detecting element comprises: a semiconductor substrate having a first major surface and a second major surface opposite each other; a first reflective layer, an absorptive layer, a phase adjusting layer, and a second reflective layer sequentially disposed, from the semiconductor substrate, on the first major surface of the semiconductor substrate; and an anti-reflection film on the second major surface of the semiconductor substrate, The first reflective layer is a multilayer reflective layer including laminated semiconductor layers having different refractive indices; the absorptive layer has a band gap energy smaller than band gap energy of the semiconductor substrate; the phase adjusting layer has a band gap energy larger than the band gap energy of the absorptive layer; and the first reflective layer contacts the absorptive layers without intervention of other layers.

A detection device includes a flow channel for a fluid sample, a suction section adapted to draw the fluid sample into the flow channel, an optical device disposed in the flow channel, a light source adapted to irradiate the optical device with light, a light detection section adapted to detect light emitted from the optical device, a microbalance sensor chip having a piezoelectric substrate provided with an oscillation electrode, and disposed in the flow channel, and a quantitative analysis section adapted to perform quantitative analysis on the fluid sample based on output from the light detection section and the microbalance sensor chip. The optical device has a metal nanostructure including projections ranging in size from 1 through 1000 nm, and emits light representing the fluid sample adsorbed to the metal nanostructure.

A phosphor material according to an embodiment of the present disclosure contains a major component represented by the formula A2-v-w-x-yBvLnwEuxSmyM2-zDzO8, where A is one or more elements selected from the group consisting of alkaline-earth metal elements; B is one or more elements selected from the group consisting of alkali metal elements; Ln is one or more elements selected from the group consisting of rare-earth elements other than Eu and Sm; M is one or more elements selected from the group consisting of W and Mo; D is one or more elements selected from the group consisting of Nb and Ta; and v, w, x, y, and z satisfy the inequalities 0≦v≦0.5, 0.15≦x+y≦0.7, 0≦y≦0.05, and 0<z≦1.7 and the equation w+x+y=v+z.

The invention discloses a kit used for detecting the colorectal cancer and application of the kit. The kit comprises nucleotide sequences in an oligonucleotide premix group I, wherein the nucleotide sequences comprise SEQ ID NO.01, SEQ ID NO.02, SEQ ID NO.03, SEQ ID NO.04, SEQ ID NO.05, SEQ ID NO.06, SEQ ID NO.07, SEQ ID NO.08, SEQ ID NO.09 AND SEQ ID NO.10. With the kit, the colorectal cancer canbe diagnosed, and the kit has the advantages of being high in sensitivity, good in specificity, short in detection time, high in popularity and stable in detection result.

The invention discloses a pharmaceutical composition for treating intractable epilepsy and application thereof. The active components of the pharmaceutical composition comprise sodium valproate or divalproex sodium and ethambutol or medicinal salt thereof. The pharmaceutical composition has the advantages that the fact that low-dose ethambutol hydrochloride has an anti-epileptic effect is discovered for the first time, the ethambutol hydrochloride is combined with the sodium valproate or divalproex sodium to treat the intractable epilepsy, the pharmaceutical composition is evident in anti-epileptic effect, and the toxic and side effects of the pharmaceutical composition are lowered evidently.

The invention discloses a medicinal composition for treating fracture healing, relating to the technical field of traditional Chinese medicines. The medicinal composition is prepared from the following Chinese medicinal materials in parts by weight: 8-12 parts of rhubarb, 12-16 parts of fortune's drynaria rhizome, 8-12 parts of pseudo-ginseng root, 12-18 parts of large-head atractylodes rhizome, 10-14 parts of safflower, 10-15 parts of officinal magnolia bark, 10-15 parts of Chinese eaglewood, 15-20 parts of barbary wolfberry fruit and 10-13 parts of garden balsam stem. The medicinal composition can be used for accelerating fracture healing, and plays a remarkable role in maintaining bone form and increasing the bone forming rate.

The invention discloses a traditional Chinese medicinal composition for nursing and treating tristimania. The traditional Chinese medicinal composition is prepared from the following traditional Chinese medicinal materials in parts by weight: 8-15 parts of poria cocos, 8-15 parts of ligusticum chuanxiong, 8-15 parts of polygala tenuifolia, 8-15 parts of radix ophiopogonis, 25-35 parts of fructus aurantii immaturus, 25-35 parts of lilium davidii duchartre, 25-35 parts of semen coicis, 25-35 parts of fructus tritici levis, 10-16 parts of rhizoma acori graminei and 4-8 parts of fructus schizandrae. The traditional Chinese medicinal composition provided by the invention is remarkable in efficacy, and meanwhile, the side-effect is obviously reduced, and the administration dependency of a patient is high.

The invention discloses a Chinese medicinal composition for promoting osteoporotic fracture healing, and relates to the technical field of Chinese medicinal compositions. The Chinese medicinal composition is prepared from the following Chinese medicinal materials in part by weight: 15 to 20 parts of Chinese angelica, 15 to 20 parts of twotooth achyranthes root, 20 to 25 parts of peach seed, 12 to18 parts of tangerine peel, 20 to 25 parts of safflower, 8 to 12 parts of notoginseng root, 10 to 15 parts of beautiful sweetgum fruit, 15 to 20 parts of suberect spatholobus stem, 10 to 15 parts of liquoric root and 30 to 40 parts of honey. The Chinese medicinal composition can prevent osteopenia of patients who suffer from osteoporotic fractures, so that bone mass is close to normal femoral density, and has obvious effects in aspects of maintaining bone forms and improving the speed of bone formation.

The invention discloses a traditional Chinese medicine composition for treating osteoporosis, which is prepared from the following traditional Chinese medicine materials in parts by weight: 8-12 parts of spina date seed, 8-12 parts of rhizoma atractylodis, 8-12 parts of rhizoma anemarrhenae, 10-15 parts of burdock, 10-15 parts of the bark of eucommia, 10-15 parts of cortex lycii radicis, 15-20 parts of folium artemisiae argyi, 15-20 parts of dandelion, 15-20 parts of caulis spatholobi, and 15-20 parts of the root of bidentate achyranthes. The traditional Chinese medicine composition disclosed by the invention is not only capable of inhibiting bone resorption but also capable of stimulating stone formation; simultaneously, the treatment cost is low; and the patient dependency is high.

The invention discloses a postoperative anesthetic anodyne and a preparation method and application thereof. The anodyne is ethyl acetate extract of hibiscus syriacus L. leaves, can effectively relieve pains of patients, decrease the occurrence rate of complications and improve success and safety of operations, is convenient to use and low in toxic and side effects and can improve medicine dependence of patients.

A gas sensor according to the present invention is a resistance-type gas sensor including: an oxide semiconductor layer (11) composed of an oxide containing cerium (11a,11b); and detection electrodes (12) for detecting the resistivity of the oxide semiconductor layer. The oxide semiconductor layer includes an alumina-containing layer (11a) in which alumina is contained, and the detection electrodes (12) are disposed in contact with the alumina-containing layer (11a).

The present invention discloses a topical drug combination for promotion of fracture healing and application, the topical drug combination comprises an active component and a medicinal supplementary material, and the active component is prepared from root of wallich swallowwort and alangium platanifolium as Chinese herbal medicine raw materials. The topical drug combination can promote the fracture healing, and improve the biomechanical characteristics of compression resistance and fracture resistance of bones of elderly osteoporotic patients through increase of femoral maximum load and elastic ratio of osteoportic fracture patients.

The invention discloses a medicine for treating breast cancer and a preparation method and application thereof. The medicine is prepared from the following raw materials in parts by weight: 3 to 7 parts of tea polyphenol, 7 to 15 parts of diclofenac sodium, 1 to 3 parts of folic acid and 11 to 19 parts of inositol. The preparation method comprises the following steps of mixing the tea polyphenol, the diclofenac sodium and the inositol, adding deionized water with mass equal to three times of masses of the polyphenol, the diclofenac sodium and the inositol, and treating by microwaves for 8min, so as to obtain a mixture A; mixing the mixture A and the folic acid, treating by ultrasonic waves for 20min at the temperature of 40 DEG C, and stirring at the temperature of 45 DEG C until a dry state is reached, so as to obtain the medicine. The medicine has the advantages that under the synergistic action of the raw materials, the therapy effect is obvious when the breast cancer is treated; the toxic or side effect is low, and an unexpected technical effect is obtained; the raw materials are simple, and easy to obtain, the administration dosage is little, the therapy effect is high, and any toxic or side effect is avoided; the medicine is used for treating the breast cancer, the preparation technology is simple, the cost is low, and the medicine is suitable for large-scale popularization.

The luminance of a transmission mode X-ray scintillator diamond plate is dominated by induced defect centers having an excited state lifetime less than 10 msec, and in embodiments less than 1 msec, 100 usec, 10 used, 1 used, 100 nsec, or even 50 nsec, thereby providing enhanced X-ray luminance response and an X-ray flux dynamic range that is linear with X-ray flux on a log-log scale over at least three orders of magnitude. The diamond plate can be a single crystal having a dislocation density of less than 104 per square centimeter, and having surfaces that are ion milled instead of mechanically polished. The defect centers can be SiV centers induced by silicon doping during CVD diamond formation, and / or NV0 centers formed by nitrogen doping followed by applying electron beam irradiation of the diamond plate and annealing.